Evidence standards in clinical nutrition
Clinical nutrition demands a high standard of evidence. Phycocyanin has been studied for antioxidant and immune-related properties, and ongoing research continues to characterise its effects. Any clinical application must rest on robust, applicable evidence and regulatory approval.
What rigorous use requires
For regulated applications, documented purity, consistent specification, contaminant testing and traceability are essential. Claims must remain strictly within demonstrated effects and the applicable regulatory framework.
Quality as the foundation
Well-characterised, high-purity inputs with complete documentation are the basis for any credible clinical nutrition evaluation. Quality consistency underpins both research integrity and regulatory compliance.
Forward-looking note: SPIRUVA is in a pre-launch phase, with commercial production scheduled for July 2027. Market figures reflect published industry trends and are directional, not guarantees.
◦ Premium Download
Get the typeset PDF report.
Branded, beautifully formatted, sharable with your procurement, R&D, and formulation teams.
About the Author
Spiruva Research Team
Industry Intelligence Desk
Spiruva's editorial team includes co-founders and industry researchers covering the global phycocyanin and spirulina markets. We publish data-driven articles that help B2B buyers make better procurement decisions.